Mohammad Alshaer, Heiko Babel, Benjamin Engelhardt, Michael Charles Burns, Yinuo Pang, Apurvasena Parikh. "Exposure-response analyses from a randomized dose optimization study of telisotuzumab adizutecan (Temab-A) in combination with bevacizumab in patients with metastatic colorectal cancer (mCRC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.132